Pro
tocols should be in line with OECD Guideline 471 (Salmonella typhimuri
um Reverse Mutation Test), 472 (Escherichia coli Reverse Mutation T
est), 473 (in vitro Mammalian Chromosomal Aberration Test), 474 (Mammalian Erythrocyte Micronucleus Test), 475 (Mammalian Bone Marrow Chromosomal Aberration Test), 476 (in vitro Mammalian Cell Gene Mutation Test) or 482 (Unscheduled DNA Synthesis in Mammalian Cells in vitro), as well as other r
...[+++]elevant OECD Guidelines for in vitro and in vivo assays.De protocollen moeten
in overeenstemming zijn met OESO-richtsnoer 471 (Salmonella typhimuri
um Reverse Mutation Test), 472 (Escherichia coli Reverse Muta
tion Test), 473 (in vitro Mammalian Chromosomal Aberration Test), 474 (
Mammalian Erythrocyte Micronucleus Test), 475 (
Mammalian Bone Marrow Chromosomal Aberration Test), 476 (in vitro
Mammalian Cell
...[+++]Gene Mutation Test) of 482 (Unscheduled DNA Synthesis in Mammalian Cells in vitro) en met andere relevante OESO-richtsnoeren voor in-vitro- en in-vivotests.